Results 151 to 160 of about 6,615 (212)

Recent advances in structural modifications of natural products for anti-leishmaniasis therapy (2010-2024). [PDF]

RSC Med Chem
Sun FQ, Quan YS, Shen QK, Guo HY, Yin XM, Quan ZS.   +5 more
europepmc   +1 more source

Leishmania amazonensis impairs phagosome acidification in B-1 phagocytes as an unrecognized parasite infection and proliferation mechanism. [PDF]

Sci Rep
Ferreira NS, Ferreira TCS, Sauter IP, Brandt-Almeida D, Staquicini DI, de Assis JB, de Oliveira VC, Júnior JWBD, Claser C, Popi AF, Pasqualini R, Arap W, Cortez M.   +12 more
europepmc   +1 more source

Exploring the <i>in vitro</i> and <i>in vivo</i> antileishmanial potential of Marizomib against <i>Leishmania amazonensis</i> and <i>Leishmania infantum</i>. [PDF]

Antimicrob Agents Chemother
Machado PdA, Gomes PS, Granato JdT, Lemos ASdO, Vicente B, Midlej VdV, Coimbra ES, de Matos Guedes HL.   +7 more
europepmc   +1 more source

Unleashing the immune modulatory potential of <i>Leishmania amazonensis-</i>derived extracellular vesicles in American cutaneous leishmaniasis. [PDF]

Front Mol Biosci
de Freitas BE, Rodrigues A, Palma-Marques J, Weber JI, Valério-Bolas A, Soares RP, Torrecilhas AC, Ferla M, Muhammad Abdel Baqui M, Gonzales Cordova RA, Alexandre-Pires G, Pereira da Fonseca I, de Andrade HM, Santos-Gomes G.   +13 more
europepmc   +1 more source

A comprehensive revision on the use of quinoline antimalarial drugs as leishmanicidal agents. [PDF]

Front Chem
Avanzo RE, García Liñares G, Rodríguez N, Romero AH.   +3 more
europepmc   +1 more source

Occurrence of Leishmania spp. in Roadkilled Wild Mammals on Highways in the State of São Paulo, Brazil. [PDF]

Rev Soc Bras Med Trop
Garavito SJO, Chouman IH, Suarez PEN, Lugo MAA, Dias RA, Dias JLC, Laurenti MD, Matta VLRD, Momo C.   +8 more
europepmc   +1 more source

Cutaneous leishmaniasis: epidemiology, treatment access and translational challenges of topical therapies. [PDF]

Front Microbiol
Carrer DC, Papera F, Ríos DN.
europepmc   +1 more source

Modulation of fibroblast behavior by Leishmania: a pathway to understanding disease progression in cutaneous leishmaniasis. [PDF]

BMC Microbiol
de Queiroz Filho TN, Costa BF, Rodrigues APD.   +2 more
europepmc   +1 more source

In Vitro Assessment of the Combined Activity of Amphotericin B and Cu²⁺-1,10-Phenanthroline-5,6-dione Coordination Compound Against Leishmania amazonensis Promastigotes. [PDF]

Trop Med Infect Dis
de Oliveira SSC, Batista DD, Devereux M, McCann M, Fernandes C, Dos Santos ALS, Branquinha MH.   +6 more
europepmc   +1 more source

Cutaneous leishmaniasis: emerging insights in epidemiology, diagnosis, and treatment. [PDF]

Front Pharmacol
Kumar N, Kakru DK, Arcot R, Lakhanpal S, Singh SK, Kumar S, Reneus Paul J.   +6 more
europepmc   +1 more source